Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation...

Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing - Manson-Bahr et al. - Journal of Clinical Pathology

This is a methodology paper from us that describes a new technique for obtaining DNA from prostate cancer biopsy tissue stored in FFPE.  We go on to show that the quantity and quality of DNA is good enough for targeted next-generation sequencing to be performed reliably.  This is important because it shows that targeted sequencing can be used as a test in the clinic without changes to the pathology processing that is currently performed in hospitals.
http://jcp.bmj.com/content/early/2015/01/13/jclinpath-2014-202754.abstract

Comments

Popular posts from this blog

A census of amplified and overexpressed human cancer genes : Nature Reviews Cancer

RT @CancerInNorwich: 📢 Join us on Monday at 1pm for the next talk in our virtual seminar series. We will be hearing from Dr Wafa Al-Jamal from @QUBelfast, who will be talking about "Smart Nanomedicimes for Pancreatic Cancer". All are welcome to join via the MS Teams link: https://t.co/4xCYpjGuBZ https://t.co/EGyD4NAgeP

Universal Scrobbler